[1]
Reham Nasser Alosaimi et al. 2024. Antidiabetic Treatment with Gliptins Focus on Cardiovascular Effects and Outcomes. International Journal of Medical Toxicology and Legal Medicine. 27, 2S (Nov. 2024), 1059–1065.